EyePoint develops sustained-release treatments for retinal diseases, leveraging proprietary technology and strategic industry partnerships.
Percheron Therapeutics Limited (ASX:PER), an international biotechnology company focused on the development of novel therapies for oncology and rare diseases, has announced a non-renounceable ...
Percheron Therapeutics Limited (ASX: PER), a company focused on developing innovative therapeutic solutions, is launching a ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results